%0 Journal Article
%T The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment.
%A van der Meijs NL
%A Travecedo MA
%A Marcelo F
%A van Vliet SJ
%J Expert Opin Ther Targets
%V 28
%N 7
%D 2024 Jul 3
%M 38946482
%F 6.797
%R 10.1080/14728222.2024.2374743
%X <B>UNASSIGNED: </B>CLEC10A is a C-type lectin receptor that specifically marks the conventional dendritic cell subsets two and three (cDC2 and DC3). It has a unique recognition profile of glycan antigens, with terminal N-Acetylgalactosamine residues that are frequently present in the tumor microenvironment. Even though CLEC10A expression allows for precise targeting of cDC2 and DC3 for the treatment of cancer, CLEC10A signaling has also been associated with anti-inflammatory responses that would promote tumor growth.<BR><B>UNASSIGNED: </B>Here, we review the potential benefits and drawbacks of CLEC10A engagement in the tumor microenvironment. We discuss the CLEC10A-mediated effects in different cell types and incorporate the pleiotropic effects of IL-10, the main anti-inflammatory response upon CLEC10A binding.<BR><B>UNASSIGNED: </B>To translate this to a successful CLEC10A-mediated immunotherapy with limited tumor-promoting capacities, finding the right ligand presentation and adjuvant combination will be key.